Anavex Life Sciences Corp (AVXL)

[crescentmotor]

I suggest you listen to Sandra Boenisch in the CC state the 4 year cash runway.

Yes--I was unaware that she said that but that would not be true even at the low current level of expenses so I don't buy what she is saying. Running the Schizophrenia Phase II and any additional required trials for AD and/or Rett would absolutely torpedo the current cash balance long before four years expired. Those safe harbor statements can be very dangerous.

I'll stick with my opinion that Anavex is making progress.

I will agree with you once AVXL files it MAA in Europe and the FDA confirms there is a regulatory path forward for 2-73 in AD toward approval in the U.S.

It is the end result that counts, not the bumps in the road as it gets there.

I hope at some point we can all look back and, for AVXL, see the truth in that statement.